Zynerba Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ZYNE Zynerba Pharmaceuticals Inc
ARVN Arvinas Inc
FOUR Shift4 Payments Inc
UK Ucommune International Ltd
CRDF Cardiff Oncology Inc
TRNR Interactive Strength Inc
OMGA Omega Therapeutics Inc
ACST Acasti Pharma Inc
PYPD PolyPid Ltd
ACRX AcelRx Pharmaceuticals Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Zynerba Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. The Company is engaged in improving the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome (FXS), and chromosome 22q11.2 deletion syndrome (22q). It is focused on using cannabinoids for treating behavioral symptoms of FXS and 22q. It is developing Zygel (ZYN002), a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol (THC). It uses a patent protected formulation containing ethanol and propylene glycol as solubilizing agents and Transcutol HP as a permeation enhancer. Zygel is an investigational drug product in development for the potential treatment of behavioral symptoms associated with FXS, 22q, and autism spectrum disorder (ASD).

Postmarket

Last Trade
Delayed
$1.27
0.0005 (0.04%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$1.27
Day's Change
-0.01 (-0.78%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
1.32
Day's Low
1.26
Volume
(Below Average)
Volume:
1,294,036

10-day average volume:
1,447,612
1,294,036
  • Prev Close
    1.28
  • Today's Open
    1.27
  • Day's Range
    1.26-1.32
  • Avg Vol (10-day)
    1.4M
  • Last (time)
    4:00p ET 09/27/23
  • Last (size)
    1
  • 52-Wk Range
    0.25 - 1.40
    LowHigh
  • (07/11/23 - 09/15/23)
    9.29%
  • 154.8%
  • Market Cap
    68.5M
  • Shares Outstanding
    53.9M
  • -0.80
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.3
  • 19.30
  • (% of float 09/15/23)
    0.46

Latest News

September 27, 2023
8:00 am ET
PR Newswire
September 14, 2023
4:15 pm ET
Globe Newswire
September 07, 2023
10:36 am ET
Globe Newswire
10:15 am ET
Globe Newswire
September 06, 2023
12:28 am ET
PR Newswire
August 31, 2023
11:25 am ET
Globe Newswire
10:32 am ET
Globe Newswire
August 29, 2023
8:18 am ET
PR Newswire
August 28, 2023
10:23 am ET
PR Newswire
August 24, 2023
1:15 pm ET
Accesswire
12:17 pm ET
Globe Newswire
11:47 am ET
Accesswire
11:07 am ET
Globe Newswire
August 22, 2023
5:59 am ET
PR Newswire
August 21, 2023
1:30 pm ET
Accesswire
August 18, 2023
5:02 am ET
Accesswire
August 17, 2023
9:31 am ET
PR Newswire
12:00 am ET
Globe Newswire
August 16, 2023
8:08 pm ET
Globe Newswire
August 15, 2023
4:20 pm ET
Accesswire
11:35 am ET
Newsfile
9:31 am ET
PR Newswire
August 14, 2023
8:01 pm ET
Accesswire
6:00 pm ET
Globe Newswire
3:58 pm ET
Globe Newswire
9:19 am ET
MarketWatch
8:45 am ET
BusinessWire
7:30 am ET
PR Newswire
August 08, 2023
4:05 pm ET
Globe Newswire
July 25, 2023
5:18 pm ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.